Training family members and carers of opiate users in overdose management and naloxone administration

Training family members and carers of opiate users in overdose management naloxone administration: a randomised trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN76786302

Enrollment

128

Registered

2010-05-05

Start date

2009-10-09

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid overdose Mental and Behavioural Disorders Mental and behavioural disorders due to use of opioids

Interventions

Intervention group: The short-term objective of the training session is to produce an increase in knowledge, skills and positive attitudes towards managing an overdose. A group-based i

an explanation of how naloxone reverses an opiate overdose

actions that should be taken and how naloxone should be administered. There will also opportunity for discussions and to clarify doubts and concerns on the topic. 2. The second stage w

this will be facilitated by the project. Feedback form will be administered by the end of the session to assess quality and participants'

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older, either sex 2. To have at least one family member (e.g., parent, partner, sibling, carer) who uses opioids 3. Opioid being the main drug type taken by their relative 4. To have sufficient knowledge of English to understand the study protocol, intervention and the research instruments

Exclusion criteria

Exclusion criteria: 1. Not having close contact with the opioid user (e.g., if they do not live in same house or frequently visiting) 2. Already trained in overdose management and naloxone administration in the past 3 years 3. Not interested in taking part in the study 4. Not willing to accept randomisation

Design outcomes

Primary

Measure	Time frame
Measured at 6 and 12 months: 1. Scores on the Overdose Knowledge Scale (OD-KS): risk, signs, action and naloxone domains and totals score 2. Scores on the Overdose Attitudes Scale (OD-AS): competence, concerns and readiness domains and total score	—

Secondary

Measure	Time frame
Measured at 6 and 12 months: 1. Characteristics of the sample 2. Number of family members who requested and successfully obtained a naloxone supply after interventions 3. Number of family members who witnessed, experienced and managed an overdose at 3, 6 and 12 months after the intervention 4. Preferable route and device of naloxone administration stated by family members 5. Trainers' and trainees' feedback on the group-based training 6. Scores in the Symptom Rating Test	—

Measure

Time frame

Measured at 6 and 12 months: 1. Characteristics of the sample 2. Number of family members who requested and successfully obtained a naloxone supply after interventions 3. Number of family members who witnessed, experienced and managed an overdose at 3, 6 and 12 months after the intervention 4. Preferable route and device of naloxone administration stated by family members 5. Trainers' and trainees' feedback on the group-based training 6. Scores in the Symptom Rating Test

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026